NCT01612507View on ClinicalTrials.gov

A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

600 mg Ceftaroline fosamil

1 h infusion

DRUG

Placebo

1 h infusion

DRUG

600 mg Ceftaroline fosamil

2 h infusion

DRUG

Placebo

2 h infusion

Trial Locations (1)

Unknown

Research site, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01612507 - A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects | Biotech Hunter | Biotech Hunter